239 related articles for article (PubMed ID: 16164913)
1. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins.
MacDonald HR; Silverstein MJ; Mabry H; Moorthy B; Ye W; Epstein MS; Holmes D; Silberman H; Lagios M
Am J Surg; 2005 Oct; 190(4):521-5. PubMed ID: 16164913
[TBL] [Abstract][Full Text] [Related]
2. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
[TBL] [Abstract][Full Text] [Related]
3. Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast.
Macdonald HR; Silverstein MJ; Lee LA; Ye W; Sanghavi P; Holmes DR; Silberman H; Lagios M
Am J Surg; 2006 Oct; 192(4):420-2. PubMed ID: 16978941
[TBL] [Abstract][Full Text] [Related]
4. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
[TBL] [Abstract][Full Text] [Related]
5. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.
Lagios MD; Silverstein MJ
Surg Oncol Clin N Am; 1997 Apr; 6(2):385-92. PubMed ID: 9115503
[TBL] [Abstract][Full Text] [Related]
6. Predictors of local recurrence following excision alone for ductal carcinoma in situ.
Hetelekidis S; Collins L; Silver B; Manola J; Gelman R; Cooper A; Lester S; Lyons JA; Harris JR; Schnitt SJ
Cancer; 1999 Jan; 85(2):427-31. PubMed ID: 10023711
[TBL] [Abstract][Full Text] [Related]
7. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Boyages J; Delaney G; Taylor R
Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735
[TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ: size and resection volume predict margin status.
Melstrom LG; Melstrom KA; Wang EC; Pilewskie M; Winchester DJ
Am J Clin Oncol; 2010 Oct; 33(5):438-42. PubMed ID: 20023569
[TBL] [Abstract][Full Text] [Related]
9. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
10. Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation.
Wazer DE; Jabro G; Ruthazer R; Schmid C; Safaii H; Schmidt-Ullrich RK
Radiat Oncol Investig; 1999; 7(2):111-7. PubMed ID: 10333252
[TBL] [Abstract][Full Text] [Related]
11. Sampling of secondary margins decreases the need for re-excision after partial mastectomy.
Guidroz JA; Larrieux G; Liao J; Sugg SL; Scott-Conner CE; Weigel RJ
Surgery; 2011 Oct; 150(4):802-9. PubMed ID: 22000194
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ
Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342
[TBL] [Abstract][Full Text] [Related]
13. An argument against routine use of radiotherapy for ductal carcinoma in situ.
Silverstein MJ
Oncology (Williston Park); 2003 Nov; 17(11):1511-33; discussion 1533-4, 1539, 1542 passim. PubMed ID: 14682107
[TBL] [Abstract][Full Text] [Related]
14. Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age.
Schouten van der Velden AP; Peeters PH; Koot VC; Hennipman A
Ann Surg Oncol; 2006 Jul; 13(7):990-8. PubMed ID: 16788762
[TBL] [Abstract][Full Text] [Related]
15. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
16. Margin status after breast-conserving treatment of breast cancer: how much free margin is enough?
von Smitten K
J Surg Oncol; 2008 Dec; 98(8):585-7. PubMed ID: 19072849
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
18. Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ.
Childs SK; Chen YH; Duggan MM; Golshan M; Pochebit S; Punglia RS; Wong JS; Bellon JR
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):948-52. PubMed ID: 22975615
[TBL] [Abstract][Full Text] [Related]
19. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM
Breast J; 2006; 12(4):331-7. PubMed ID: 16848842
[TBL] [Abstract][Full Text] [Related]
20. Ductal carcinoma in situ of the breast -- among factors predicting for recurrence, distance from the nipple is important.
Stallard S; Hole DA; Purushotham AD; Hiew LY; Mehanna H; Cordiner C; Dobson H; Mallon EA; George WD
Eur J Surg Oncol; 2001 Jun; 27(4):373-7. PubMed ID: 11417983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
